Veeral Sheth, MD
Enriched profilePartner and Director of Clinical Trials/Research, University Retina and Macula Associates · University Retina and Macula Associates
Veeral Sheth is Partner and Director of Clinical Trials/Research, University Retina and Macula Associates at University Retina and Macula Associates. OpenAlex indexes 67 publications with 2,095 citations (h-index 20); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 31 Aug 2026
Veeral S. Sheth, MD, is Partner and Director of Clinical Trials/Research, University Retina and Macula Associates. The public record shows 67 publications with 2,095 citations (h-index 20), centered on Diabetic Retinopathy / DME. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 27 companies.
- Most recent indexed publication: 2025 · Ophthalmology and therapy
- Top research focus: Diabetic Retinopathy / DME
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 27 companies
Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 31 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
Industry payments
Updated 31 Aug 2026
27 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- F. Hoffmann-La Roche AGProgram year202516 payments$38,758openpaymentsdata.cms.gov ↗
- Genentech USA, Inc.Program year202515 payments$30,850openpaymentsdata.cms.gov ↗
- Astellas Pharma US IncProgram year20257 payments$27,463openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
98.4%Antineovascularisation agents92.1%Faricimab-svoa100%Part B, office-administered≥109 patientsComplement Inhibitor5.7%Avacincaptad pegol100%Part B, office-administered≥15 patientsCancer & immunology
1.2%Vascular Endothelial Growth Factor Inhibitor1.2%Aflibercept74%Bevacizumab26%Part B, office-administered≥39 patientsMusculoskeletal
0.2%Cyclooxygenase Inhibitor0.2%Ketorolac Tromethamine100%Part D≥42 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 31 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Does the Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema in Randomized Trials Translate into Real-World Settings?
Ophthalmology and therapy
Editorial2025 - Long-Term Control of Retinal Thickness Variability and Vision Following the 0.19 mg Fluocinolone Acetonide Implant.
Journal of vitreoretinal diseases
Article2023 - Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration.
Biomedicines
Review2022 - Fluctuations in central foveal thickness and association with vision outcomes with anti-VEGF therapy for nAMD: HARBOR post hoc analysis.
BMJ open ophthalmology
Clinical Trial2022
Online presence
Updated 31 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/veeral-sheth-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/veeral-sheth-md-mba-fasrs-6672a031
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Sheth-Veeral
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/reel/DQFfoKMjeGg
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗ - Other
asrs.org/find-a-specialist/profile/7792
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗ - Other
hcplive.com/authors/veeral-sheth-md-mba-fasrs-facs
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 31 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
University of Illinois College of Medicine at Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uretina.com ↗ - M.B.A.
Northwestern University Kellogg School of Management
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uretina.com ↗ - Ophthalmology Residency
University of Illinois at Chicago / Illinois Eye and Ear Infirmary (Chief Resident)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uretina.com ↗ - Vitreoretinal Fellowship
University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uretina.com ↗ - Board certified
Ophthalmology (ABMS)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- Active member
American Society of Retina Specialists (ASRS); Fellow (FASRS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uretina.com ↗ - Active member
American Academy of Ophthalmology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uretina.com ↗ - Active member
Association for Research in Vision and Ophthalmology (ARVO)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uretina.com ↗
Secondary affiliations
appointments beyond the home institution- Clinical Assistant Professor
University of Illinois at Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uretina.com ↗ - Affiliated physician
Advocate Christ Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →advocatehealth.com ↗ - Affiliated physician
Silver Cross Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.silvercross.org ↗
Media & interviews
press, podcasts and appearances- Host of "New Insight with Veeral Sheth, MD" podcast/video series on HCPLive
covering ophthalmology news and pipeline interviews
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →brightfocus.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →retinalphysician.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore